Loading company…
Myriad Genetics provides genetic tests for hereditary risks, cancer treatment and prenatal care.
Founded in 1992 and headquartered in Salt Lake City, US, Myriad Genetics provides genetic testing services for patients and healthcare professionals. Its germline and tumor genomic tests support hereditary cancer risk assessment, treatment decisions and prenatal care. In 2024, Myriad reported revenue of USD 837.60 mn. On July 31, 2025, it raised USD 4.80 mn through a PIPE from New Venturetec.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in